Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1716 ARTÍCULOS , VIENDO DEL 196 AL 210

Selective Secretase Targeting for Alzheimer's Disease Therapy

Miranda A, Montiel E, Ulrich H, Paz C.

J Alzheimers Dis. 2021;81(1):1-17. doi: 10.3233/JAD-201027.

Polyphenol-Peptide Interactions in Mitigation of Alzheimer's Disease: Role of Biosurface-Induced Aggregation

Gaudreault R, Hervé V, van de Ven TGM, Mousseau N, Ramassamy C.

J Alzheimers Dis. 2021;81(1):33-55. doi: 10.3233/JAD-201549.

Genetic pleiotropy and the shared pathological features of corticobasal degeneration and progressive supranuclear palsy: a case report and a review of the literature

Rini J, Asken B, Geier E, Rankin K, Kramer J, Boxer A, Miller B, Yokoyama J, Spina S.

Neurocase. 2021 Apr;27(2):120-128. doi: 10.1080/13554794.2021.1879869. Epub 2021 Mar 23.

Validation of the Chinese Version of the Relevant Outcome Scale for Alzheimer's Disease (CROSA)

Zhang S, Qi J, Yang Q, Guo Q.

Int Psychogeriatr. 2021 Nov;33(11):1193-1205. doi: 10.1017/S1041610221000247. Epub 2021 Mar 24.

Exposure to gamma tACS in Alzheimer's disease: A randomized, double-blind, sham-controlled, crossover, pilot study

Benussi A, Cantoni V, Cotelli MS, Cotelli M, Brattini C, Datta A, Thomas C, Santarnecchi E, Pascual-Leone A, Borroni B.

Brain Stimul. 2021 May-Jun;14(3):531-540. doi: 10.1016/j.brs.2021.03.007. Epub 2021 Mar 21.

Genetic Variants Associated With Alzheimer Disease in the 22 Arab Countries: A Systematic Review

Al-Thani HF, Ahmad MN, Younes S, Zayed H.

Alzheimer Dis Assoc Disord. 2021 Apr-Jun 01;35(2):178-186. doi: 10.1097/WAD.0000000000000447.

Novel Presenilin-1 Mutation (Ala275Ser) Associated With Clinical Features of Dementia With Lewy Bodies

Joshi P, Gardner M, Lintott C, Anderson T.

Alzheimer Dis Assoc Disord. 2021 Oct-Dec 01;35(4):350-352. doi: 10.1097/WAD.0000000000000444.

Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer's disease already receiving donepezil: a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trial

Koh SH, Kwon HS, Choi SH, Jeong JH, Na HR, Lee CN, Yang Y, Lee AY, Lee JH, Park KW, Han HJ, Kim BC, Park JS, Lee JY, Kim S, Lee KY.

Alzheimers Res Ther. 2021 Mar 26;13(1):66. doi: 10.1186/s13195-021-00803-w.

Alterations and interactions of subcortical modulatory systems in Alzheimer's disease

Babić Leko M, Hof PR, Šimić G.

Prog Brain Res. 2021;261:379-421. doi: 10.1016/bs.pbr.2020.07.016. Epub 2021 Jan 20.

A systematic review and meta-analysis of the clinical effects of Souvenaid in patients with Alzheimer's disease

Shim Y, Yoon B, Na S, Lim EY, Hong YJ, Yang DW.

Asia Pac J Clin Nutr. 2021;30(1):30-41. doi: 10.6133/apjcn.202103_30(1).0005.

Mitochondrial Dysfunction and Mitophagy Closely Cooperate in Neurological Deficits Associated with Alzheimer's Disease and Type 2 Diabetes

Paul S, Saha D, Bk B.

Mol Neurobiol. 2021 Aug;58(8):3677-3691. doi: 10.1007/s12035-021-02365-2. Epub 2021 Apr 1.

An Efficacy Trial of Long-Term Care Residents With Alzheimer's Disease Using Videos to Communicate Care Preferences

Towsley GL, Wong B, Baier RR, Neller S.

J Am Med Dir Assoc. 2021 Jul;22(7):1559-1560. doi: 10.1016/j.jamda.2021.02.032. Epub 2021 Mar 30.

Generation of induced pluripotent stem cell line (IPTi002-A) from an 87-year old sporadic Alzheimer's disease patient with APOE3 (ε3/ε3) genotype

Zhang L, Ren Q, Liu X, Liu G, Meng S, Xiahou K, Zhang Y, Jiang N, Zhou W.

Stem Cell Res. 2021 May;53:102282. doi: 10.1016/j.scr.2021.102282. Epub 2021 Mar 12.

Mitochondrial Permeability Transition: A Pore Intertwines Brain Aging and Alzheimer's Disease

Jia K, Du H.

Cells. 2021 Mar 15;10(3):649. doi: 10.3390/cells10030649.

Prospects of Marine Sterols against Pathobiology of Alzheimer's Disease: Pharmacological Insights and Technological Advances

Rahman MA, Dash R, Sohag AAM, Alam M, Rhim H, Ha H, Moon IS, Uddin MJ, Hannan MA.

Mar Drugs. 2021 Mar 20;19(3):167. doi: 10.3390/md19030167.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias